ARALKYL FORMYL-ALKYL PIPERAZINE DERIVATIVES AND THEIR USES AS CEREBRAL NERVE PROTECTIVE AGENT

Details for Australian Patent Application No. 2003236131 (hide)

Owner SHANGHAI INSTITUTE OF PHARMACEUTICAL INDUSTRY

Inventors WENG, Zhijie; ZHANG, Chunnian; LI, Jianqi; HUANG, Liying; MIN, Yang

Pub. Number AU-A-2003236131

PCT Number PCT/CN03/00273

PCT Pub. Number WO2003/095437

Priority 02111614.8 08.05.02 CN

Filing date 16 April 2003

Wipo publication date 11 November 2003

International Classifications

C07D 295/084 Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms

C07D 309/36 Heterocyclic compounds containing six-membered rings having one oxygen atom as the only ring hetero atom, not condensed with other rings

C07D 401/12 Heterocyclic compounds containing two or more hetero rings

C07D 405/12 Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom

A61K 031/495 - having six-membered rings with two nitrogen atoms as the only ring hetero atoms, e.g. piperazine

A61P 025/24 Drugs for disorders of the nervous system

C07D 295/108 Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms

C07D 295/192 Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms

C07D 213/36 Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members

C07D 215/12 Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems

Event Publications

4 September 2003 Complete Application Filed

  Priority application(s): 02111614.8 08.05.02 CN

15 January 2004 Application Open to Public Inspection

  Published as AU-A-2003236131

27 January 2005 Application Lapsed, Refused Or Withdrawn, Patent Ceased or Expired

  This application lapsed under section 142(2)(f)/See Reg. 8.3(3). Examination has not yet been requested or directed for this application. Note that applications or patents shown as lapsed or ceased may be restored at a later date.

17 December 2009 Corrigenda

  Applications OPI - Name Index Under the name Shanghai Institute of Pharmaceutical Industry , Application No. 2003236131 , under INID (43) correct the publication date to read 24.11.2003

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2003236132-ACCESS CONTROL APPARATUS AND DATA MANAGEMENT APPARATUS

2003236130-AN ASSEMBLED TYPE GOLF CLUB IN SUBSECTION